Werewolf Therapeutics provided a business update, announcing progress in their clinical trials for WTX-124, a conditionally activated therapeutic for cutaneous melanoma, with full enrollment in ...

The Salem witch trials of 1692 have gone down in history as one of the most infamous events to ever occur in America. But 200 years prior, in Europe, people were being accused of lycanthropy or ...

Full enrollment in cutaneous melanoma dose-expansion arms of Phase 1/1b clinical trial evaluating WTX-124 as monotherapy and in combination ...

Reports Q4 revenue $0 vs. $301,590. “Werewolf made considerable progress in 2024 with promising preliminary evidence of durable anti-tumor ...

which is still back n preclinical development and due to start its first clinical trials next year. Jazz and Werewolf say that WTX-613 is designed to deliver the cytokine only in the tumour ...

The Metropolitan Museum of Art, New York "The Werewolf or the Cannibal" Akin to the infamous witch trials that swept through Europe and later the United States, a number of European countries dealt ...

Werewolf continues to evaluate WTX-124 as a monotherapy and in combination with pembrolizumab through the ongoing Phase 1/1b clinical trial evaluating the INDUKINE molecule in multiple solid tumor ...